MIA3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.044000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.385600E-01
Normal-vs-Stage2
8.368400E-01
Normal-vs-Stage3
8.367900E-02
Normal-vs-Stage4
5.824400E-01
Stage1-vs-Stage2
8.423800E-01
Stage1-vs-Stage3
6.515600E-02
Stage1-vs-Stage4
4.354800E-01
Stage2-vs-Stage3
4.297500E-03
Stage2-vs-Stage4
3.595200E-01
Stage3-vs-Stage4
3.792000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.816200E-01
Normal-vs-AfricanAmerican
7.100000E-01
Normal-vs-Asian
8.715800E-01
Caucasian-vs-AfricanAmerican
3.973000E-01
Caucasian-vs-Asian
8.172200E-01
AfricanAmerican-vs-Asian
5.058000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.780400E-01
Normal-vs-Female
4.972200E-01
Male-vs-Female
5.892100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.236800E-01
Normal-vs-Age(41-60Yrs)
6.787800E-01
Normal-vs-Age(61-80Yrs)
8.821000E-01
Normal-vs-Age(81-100Yrs)
5.283200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.402200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.739200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.411800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.356200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.935400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.883400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.748600E-01
Normal-vs-Daily Drinker
3.091800E-01
Normal-vs-Weekly Drinker
9.006400E-01
Normal-vs-Occasional Drinker
8.602000E-01
Normal-vs-Social Drinker
7.563600E-01
Non Drinker-vs-Daily Drinker
1.991180E-01
Non Drinker-vs-Weekly Drinker
8.994800E-01
Non Drinker-vs-Occasional Drinker
8.672600E-01
Non Drinker-vs-Social Drinker
3.625400E-01
Daily Drinker-vs-Weekly Drinker
1.454040E-01
Daily Drinker-vs-Occasional Drinker
7.408000E-02
Daily Drinker-vs-Social Drinker
7.036000E-02
Weekly Drinker-vs-Occasional Drinker
9.968400E-01
Weekly Drinker-vs-Social Drinker
4.526800E-01
Occasional Drinker-vs-Social Drinker
4.006000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.844200E-02
Normal-vs-Grade 2
4.739700E-02
Normal-vs-Grade 3
8.155600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.991800E-01
Grade 1-vs-Grade 3
8.738800E-01
Grade 1-vs-Grade 4
7.844200E-02
Grade 2-vs-Grade 3
6.113200E-01
Grade 2-vs-Grade 4
4.739700E-02
Grade 3-vs-Grade 4
8.155600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.305800E-01
Normal-vs-NonDiabetic
6.603600E-01
Diabetic-vs-NonDiabetic
7.722200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.416600E-01
Normal-vs-NoPancreatitis
7.859600E-01
Pancreatitis-vs-NoPancreatitis
1.557160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.679400E-01
Normal-vs-N1
7.156200E-01
N0-vs-N1
1.773640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.962800E-01
Normal-vs-TP53-NonMutant
6.851200E-01
TP53-Mutant-vs-TP53-NonMutant
4.535900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
